We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

2,031 hedge funds and large institutions have $164B invested in Thermo Fisher Scientific in 2020 Q4 according to their latest regulatory filings, with 275 funds opening new positions, 751 increasing their positions, 739 reducing their positions, and 70 closing their positions.

New
Increased
Maintained
Reduced
Closed

293% more first-time investments, than exits

New positions opened: 275 | Existing positions closed: 70

10% more funds holding

Funds holding: 1,8482,031 (+183)

5% more capital invested

Capital invested by funds: $156B → $164B (+$8.53B)

2% more repeat investments, than reductions

Existing positions increased: 751 | Existing positions reduced: 739

0.99% less ownership

Funds ownership: 89.16%88.17% (-0.99%)

7% less funds holding in top 10

Funds holding in top 10: 198184 (-14)

19% less call options, than puts

Call options by funds: $976M | Put options by funds: $1.21B

Holders
2,031
Holders Change
+183
Holders Change %
+9.9%
% of All Funds
35.93%
Holding in Top 10
184
Holding in Top 10 Change
-14
Holding in Top 10 Change %
-7.07%
% of All Funds
3.26%
New
275
Increased
751
Reduced
739
Closed
70
Calls
$976M
Puts
$1.21B
Net Calls
-$229M
Net Calls Change
-$95M
Name Holding Trade Value Shares
Change
Change in
Stake
NSIM
1051
North Star Investment Management
Illinois
$1.89M -$2.34K -5 -0.1%
EF
1052
Empirical Finance
Pennsylvania
$1.89M +$334K +712 +21%
SWM
1053
Segment Wealth Management
Texas
$1.89M +$752K +1,603 +65%
AIA
1054
Angeles Investment Advisors
California
$1.89M +$96.1K +205 +5%
CIS
1055
Capital International Sarl
California
$1.88M +$194K +414 +11%
JWCA
1056
J.W. Cole Advisors
Florida
$1.88M +$232K +495 +14%
CB
1057
Cadence Bank
Mississippi
$1.87M +$1.89M +4,022 New
TNBTD
1058
Trustmark National Bank Trust Department
Mississippi
$1.86M +$741K +1,581 +65%
SCP
1059
Shorepoint Capital Partners
Massachusetts
$1.85M -$48.8K -104 -3%
QCG
1060
Quadrant Capital Group
Ohio
$1.83M +$21.1K +45 +1%
PAM
1061
Peak Asset Management
Colorado
$1.82M +$1.41K +3 +0.1%
BS
1062
Bessemer Securities
New York
$1.8M -$246K -525 -12%
PHM
1063
Prospect Hill Management
New Jersey
$1.8M +$1.82M +3,875 New
MWM
1064
Midwest Wealth Management
Indiana
$1.8M +$1.82M +3,874 New
JCM
1065
Jacobsen Capital Management
Utah
$1.8M
CAM
1066
Cypress Asset Management
Texas
$1.8M +$7.97K +17 +0.4%
FF
1067
FourThought Financial
Florida
$1.8M +$1.81M +3,859 New
RCAG
1068
Rehmann Capital Advisory Group
Michigan
$1.79M +$128K +273 +8%
MGWM
1069
Marks Group Wealth Management
Minnesota
$1.79M +$62.8K +134 +4%
JFGIW
1070
Johnson Financial Group Inc (Wisconsin)
Wisconsin
$1.79M +$82.1K +175 +5%
SIA
1071
Soltis Investment Advisors
Utah
$1.79M +$1.35M +2,876 +298%
CNBTD
1072
Citizens National Bank Trust Department
Mississippi
$1.78M +$907K +1,935 +102%
CIA
1073
Choate Investment Advisors
Massachusetts
$1.78M +$7.5K +16 +0.4%
RC
1074
Roundview Capital
New Jersey
$1.78M +$39.9K +85 +2%
JDR
1075
Jay D. Rosenbaum
$1.78M -$188K -400 -9%

TMO Hedge Fund Activity: Q4 2020 in Review

2,031 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q4 2020, worth a combined $164B — up 5.5% from $156B a quarter earlier.

Buyers outnumbered sellers: 275 funds opened new TMO positions and 70 closed out — a net gain of 205 holders — while 751 added to existing stakes and 739 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $322M. The largest seller was Capital Research Global Investors, cutting an estimated $770M.

  • 2,031 institutional investors held Thermo Fisher Scientific (TMO) as of Q4 2020, up from 1,848 in Q3 2020.
  • Funds reported $164B of Thermo Fisher Scientific stock for Q4 2020, up 5.5% quarter-over-quarter.
  • 275 funds opened new Thermo Fisher Scientific positions in Q4 2020 and 70 closed out, a net change of +205 holders.
  • The largest Thermo Fisher Scientific buyer in Q4 2020 was Fidelity Investments, an estimated $322M added.
  • The largest Thermo Fisher Scientific seller in Q4 2020 was Capital Research Global Investors, an estimated $770M sold.

Based on aggregated 13F filings for Q4 2020.